1-14 of 14
Evren Alici
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility of Co-Administration of Autologous NK Cells and Anti-CD38 Monoclonal Antibody Isatuximab, in Multiple Myeloma Post-Autologous HSCT in a Randomized Phase 2 Clinical Trial

Johan Lund, Stephan Meinke, Muhammad Kashif, Anna Bohlin, Eva Hellstrom Lindberg, Hans-Gustaf Ljunggren, Evren Alici
Journal: Blood
Blood (2024) 144 (Supplement 1): 7234.
https://doi.org/10.1182/blood-2024-212362
Published: 2024
Journal Articles

Predictive Biosignature and Risk Scoring for Bone Disease in Multiple Myeloma

Muhammad Kashif, Niki Throumpari, Katarina Uttervall, Kristin Roseth Aass, Therese Standal, Kristine Misund, Hareth Nahi, Robin Mjelle, Evren Alici, Johan Lund
Journal: Blood
Blood (2024) 144 (Supplement 1): 4686.
https://doi.org/10.1182/blood-2024-202992
Published: 2024
Journal Articles

Outcomes of Relapsed and Refractory Multiple Myeloma with the Evolving Standard of Care

Vincent Luong, Muhammad Kashif, Katarina Uttervall, Anna Bohlin, Nursen Cetrez, Gabriel Afram, Hareth Nahi, Johan Lund, Evren Alici
Journal: Blood
Blood (2024) 144 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2024-193255
Published: 2024
Journal Articles

A Lightweight Risk Scoring System for Stratification of Newly Diagnosed Multiple Myeloma Patients

Georgia Riga, Vincent Luong, Katarina Uttervall, Gösta Gahrton, Hareth Nahi, Johan Lund, Evren Alici, Muhammad Kashif
Journal: Blood
Blood (2024) 144 (Supplement 1): 3318.
https://doi.org/10.1182/blood-2024-209504
Published: 2024
Journal Articles

A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk

Muhammad Kashif, Yijie Zhou, Vincent Luong, Katarina Uttervall, Gösta Gahrton, Hareth Nahi, Evren Alici, Johan Lund
Journal: Blood
Blood (2023) 142 (Supplement 1): 1960.
https://doi.org/10.1182/blood-2023-179999
Published: 2023
Journal Articles

HSV1716 Infects Multiple Myeloma Cells and Leads to CD138 Downregulation

Katharina Helene Susek, Viktoria Nina Flore, Maria Karvouni, Stephan Meinke, Joe Conner, Colin Powers, Robert Allen, Arnika Kathleen Wagner, Evren Alici
Journal: Blood
Blood (2022) 140 (Supplement 1): 12440–12441.
https://doi.org/10.1182/blood-2022-158062
Published: 2022
Journal Articles

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Hareth Nahi, Michael Chrobook, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Gabriel Afram, Tolga Sutlu, Mari Gilljam, Birgitta Stellan, Arnika Kathleen Wagner, Lilian Walther-Jallow, Johan Liwing, Monika Klimkowska, Goesta Gahrton, Per Ljungman, Hans-Gustaf Ljunggren, Evren Alici
Journal: Blood
Blood (2021) 138 (Supplement 1): 4796.
https://doi.org/10.1182/blood-2021-152522
Published: 2021
Journal Articles

Ex Vivo Activity of Immunotherapeutic Approaches Targeting CD38 Against Daratumumab-Resistant Multiple Myeloma Patient Samples

Maria Karvouni, MSc, PharmD, Heyue Zhou, Arnika Kathleen Wagner, PhD, Qiangzhong Ma, Alamdar H. Baloch, PhD, Tong Zhu, Hong Zhang, Mari Gilljam, Andreas Lundqvist, PhD, Gunnar F. Kaufmann, PhD, Evren Alici, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1848.
https://doi.org/10.1182/blood-2019-127893
Published: 2019
Journal Articles

Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS

Ebba Sohlberg, PhD, Alvaro Haroun-Izquierdo, Andreas T Björklund, MD PhD MSc, Sarah Cooley, MD, Merete Thune Wiiger, Msc, Jodie Peter Goodridge, PhD, Hanna Julie Hoel, Aline Pfefferle, Michael Chrobook, Veronika Kremer, Eva Hellström-Lindberg, MD PhD, Eivind Heggernes Ask, Blomberg Pontus, Bahram Valamehr, PhD, Karolin Guldevall, Hanna van Ooijen, Bjorn Onfelt, Evren Alici, MD PhD, Hans-Gustaf Ljunggren, Jeffrey S. Miller, MD, Karl-Johan Malmberg, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 195.
https://doi.org/10.1182/blood-2018-195
Published: 2018
Journal Articles

Re-Challenging with Anti-CD38 Monotherapy in Triple-Refractory Multiple Myeloma Patients Is a Feasible and Safe Approach

Johan Lund, MD, Evren Alici, MD PhD, Michael Chrobok, MD, Astrid Gruber, MD PhD, Tahamtan Ahmadi, Imran Khan, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 5366.
https://doi.org/10.1182/blood.V126.23.5366.5366
Published: 2015
Journal Articles

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex

Johan Lund, MD, Sigrid Karstorp, MD, Evren Alici, MD PhD, Astrid Gruber, MD PhD, Birgitta Lauri, MD, Cecilie Blimark, MD PhD, Agneta Swedin, MD PhD, Markus Hansson, MD PhD, Karin Forsberg, MD, Lucia Ahlberg, MD, Carlsson Conny, MD, Anders Waage, MD PhD, Peter Gimsing, Annette Juul Vangsted, MD PhD, Ulf Christian Frølund, MD, Mats Hardling, Ulf-Henrik Mellqvist, MD PhD, Hareth Nahi
Journal: Blood
Blood (2015) 126 (23): 3047.
https://doi.org/10.1182/blood.V126.23.3047.3047
Published: 2015
Journal Articles

The Prognostic Significance of 8p21 Deletion in Multiple Myeloma

Hareth Nahi, Tolga Sutlu, Evren Alici, Goesta Gahrton, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5153.
https://doi.org/10.1182/blood.V112.11.5153.5153
Published: 2008
Journal Articles

Impact of Chromosome 13 Deletion and Plasma Cell Load on Long-Term Survival of Patients with Multiple Myeloma Undergoing Autologous Transplantation

Esbjörn Paul, Tolga Sutlu, Evren Alici, Goesta Gahrton, MD, PhD, Hareth Nahi
Journal: Blood
Blood (2008) 112 (11): 5148.
https://doi.org/10.1182/blood.V112.11.5148.5148
Published: 2008
Journal Articles

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Evren Alici, Tolga Sutlu, Bo Björkstrand, Mari Gilljam, Birgitta Stellan, Hareth Nahi, Hernan Concha Quezada, Gösta Gahrton, Hans-Gustaf Ljunggren, M. Sirac Dilber
Journal: Blood
Blood (2008) 111 (6): 3155–3162.
https://doi.org/10.1182/blood-2007-09-110312
Published: 2008
Includes: Supplemental data